{Reference Type}: Review {Title}: Levodopa for Dystonia in Children: A Case Series and Review of the Literature. {Author}: DeArias AL;Bamford NS; {Journal}: Pediatr Neurol {Volume}: 152 {Issue}: 0 {Year}: 2024 Mar 19 {Factor}: 4.21 {DOI}: 10.1016/j.pediatrneurol.2023.12.012 {Abstract}: BACKGROUND: Levodopa is used to treat hyperkinetic movements in children with dopa-responsive dystonia. However, levodopa may also be helpful in treating other forms of dystonia when used beyond a brief trial period.
METHODS: We performed a retrospective review of all children referred to our institution for evaluation of generalized dystonia and subsequently treated with carbidopa-levodopa. Motor function was assessed using video recordings and examination notes, quantified with the Burke-Fahn-Marsden Dystonia Rating Scale.
RESULTS: Long-term treatment with carbidopa-levodopa moderately improved motor function, whereas short-term use did not. Carbidopa-levodopa was well tolerated without untoward effects.
CONCLUSIONS: Dystonia is a significant cause of disability with limited effective treatment options. Published work is restricted but generally supports the findings of this review. A well-controlled study to examine the utility of carbidopa-levodopa treatment for dystonia is needed.